Acasti Pharma Inc (ACST.O)
ACST.O on Consolidated Issue listed on NASDAQ Capital Market
3.85USD
1 Aug 2013
3.85USD
1 Aug 2013
Price Change (% chg)
$-0.18 (-4.47%)
$-0.18 (-4.47%)
Prev Close
$4.03
$4.03
Open
$4.04
$4.04
Day's High
$4.09
$4.09
Day's Low
$3.85
$3.85
Volume
14,963
14,963
Avg. Vol
20,947
20,947
52-wk High
$4.20
$4.20
52-wk Low
$1.61
$1.61
About
Acasti Pharma Inc. (Acasti) is engaged in developing a product portfolio of long-chain omega-3 phospholipids. Acasti is a majority owned subsidiary of Neptune Technologies and Bioressources Inc. (Neptune). The Company has one operating segment: the development and commercialization of pharmaceutical applications of its licensed... (more)
Overall
| Beta: | -- |
| Market Cap (Mil.): | $331.88 |
| Shares Outstanding (Mil.): | 79.97 |
| Dividend: | -- |
| Yield (%): | -- |
Financials
| ACST.O | Industry | Sector | |
|---|---|---|---|
| P/E (TTM): | -- | 37.93 | 37.76 |
| EPS (TTM): | -0.10 | -- | -- |
| ROI: | -66.94 | 19.48 | 18.76 |
| ROE: | -66.94 | 20.17 | 19.59 |

Estimates